Loading
Latest filing published 09 Feb 2022 for Cardiovascular Systems Inc, €26k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Rhonda J. Robb, listed as chief executive, appears in our data through filings on Cardiovascular Systems Inc shares, published by SEC (Form 4). In total, 6 filings cover trades dated from 10 May 2021 to 7 February 2022.
No open-market sale appears; the market trades are 2 purchases worth €54k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants. In 2022 alone, the filings show 1 purchase and no sales.
The newest entry dates from 9 February 2022: an open-market purchase of €26k, in Cardiovascular Systems Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations